Vimian Group AB (publ) (STO:VIMIAN)

Sweden flag Sweden · Delayed Price · Currency is SEK
28.15
-0.40 (-1.40%)
Apr 28, 2026, 5:29 PM CET
-21.68%
Market Cap 14.90B
Revenue (ttm) 4.60B
Net Income (ttm) 338.73M
Shares Out 529.26M
EPS (ttm) 0.64
PE Ratio 43.69
Forward PE 21.61
Dividend n/a
Ex-Dividend Date n/a
Volume 244,030
Average Volume 253,238
Open 28.55
Previous Close 28.55
Day's Range 28.05 - 28.65
52-Week Range 24.18 - 46.00
Beta 1.18
RSI 48.21
Earnings Date Apr 29, 2026

About Vimian Group AB

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under... [Read more]

Sector Healthcare
Founded 2020
Employees 1,041
Stock Exchange Nasdaq Stockholm
Ticker Symbol VIMIAN
Full Company Profile

Financial Performance

In 2025, Vimian Group AB's revenue was 425.10 million, an increase of 13.42% compared to the previous year's 374.80 million. Earnings were 31.30 million, an increase of 69.19%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.